(Q46623115)

English

Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease

scientific article published on 25 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

1 reference

based on heuristic

inferred from title

object named as

John Pernow

4

0 references

author name string

Magnus Settergren

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

Felix Böhm

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

Lars Rydén

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

29

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

14

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

1753-1760

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Cellular antioxidant effects of atorvastatin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Ezetimibe: the first in a novel class of selective cholesterol-absorption inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Characteristics of endothelin A and B binding sites and their vascular effects in pig peripheral tissues

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Endothelial function: cardiac events

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Endothelial function in the forearm circulation of patients with the metabolic syndrome--effect of different lipid-lowering regimens

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Endothelin, hypercholesterolemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Statins have biphasic effects on angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

The issue of statin safety: where do we stand?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN166

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHN166

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18441323

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46623115&oldid=2141482602"